par Piccart-Gebhart, Martine 
Référence Annals of oncology, 24, 8, page (1951-1955)
Publication Publié, 2013-08
Référence Annals of oncology, 24, 8, page (1951-1955)
Publication Publié, 2013-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Piccart-Gebhart, Martine |
| Informations sur la publication: | Annals of oncology, 24, 8, page (1951-1955) |
| Statut de publication: | Publié, 2013-08 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antibodies, Monoclonal, Humanized -- adverse effects -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Carcinoma, Non-Small-Cell Lung -- drug therapy -- genetics | |
| Colorectal Neoplasms -- drug therapy | |
| Female | |
| Humans | |
| Individualized Medicine -- methods | |
| Lung Neoplasms -- drug therapy -- genetics | |
| Molecular Targeted Therapy -- adverse effects -- methods | |
| Quinazolines -- therapeutic use | |
| Receptor, Epidermal Growth Factor -- drug effects -- genetics -- immunology | |
| Receptor, ErbB-2 -- drug effects -- immunology | |
| Note générale: | SCOPUS: ed.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0923-7534 |
| info:doi/10.1093/annonc/mdt260 | |
| info:pii/mdt260 | |
| info:scp/84881252783 | |
| info:pmid/23878113 |
